PAS
ELVN icon

Point72 Asia (Singapore)’s Enliven Therapeutics ELVN Stock Holding History

Point72 Asia (Singapore)’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$132K Buy
6,588
+4,293
+187% +$86.1K 0.02% 423
2025
Q1 		$45.2K Buy
+2,295
New +$45.2K 0.01% 588